SIP
Stoneridge Investment Partners’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-12,958
| Closed | -$37K | – | 210 |
|
2017
Q4 | $37K | Hold |
12,958
| – | – | 0.01% | 218 |
|
2017
Q3 | $37K | Hold |
12,958
| – | – | 0.01% | 235 |
|
2017
Q2 | $32K | Sell |
12,958
-21,502
| -62% | -$53.1K | ﹤0.01% | 248 |
|
2017
Q1 | $124K | Sell |
34,460
-11,921
| -26% | -$42.9K | 0.02% | 299 |
|
2016
Q4 | $164K | Hold |
46,381
| – | – | 0.02% | 274 |
|
2016
Q3 | $187K | Sell |
46,381
-205
| -0.4% | -$827 | 0.03% | 249 |
|
2016
Q2 | $205K | Sell |
46,586
-105,466
| -69% | -$464K | 0.03% | 256 |
|
2016
Q1 | $575K | Sell |
152,052
-17,350
| -10% | -$65.6K | 0.08% | 196 |
|
2015
Q4 | $2.66M | Sell |
169,402
-41,544
| -20% | -$651K | 0.36% | 91 |
|
2015
Q3 | $2.22M | Buy |
210,946
+32,615
| +18% | +$344K | 0.31% | 101 |
|
2015
Q2 | $4.5M | Sell |
178,331
-37,707
| -17% | -$951K | 0.56% | 43 |
|
2015
Q1 | $6.02M | Buy |
216,038
+1,711
| +0.8% | +$47.7K | 0.71% | 37 |
|
2014
Q4 | $3.91M | Buy |
214,327
+35,656
| +20% | +$651K | 0.51% | 67 |
|
2014
Q3 | $2.32M | Sell |
178,671
-150
| -0.1% | -$1.94K | 0.34% | 97 |
|
2014
Q2 | $2.92M | Buy |
178,821
+129,370
| +262% | +$2.11M | 0.44% | 74 |
|
2014
Q1 | $874K | Buy |
49,451
+9,887
| +25% | +$175K | 0.17% | 96 |
|
2013
Q4 | $958K | Buy |
39,564
+18,160
| +85% | +$440K | 0.18% | 91 |
|
2013
Q3 | $758K | Sell |
21,404
-11,473
| -35% | -$406K | 0.17% | 100 |
|
2013
Q2 | $513K | Buy |
+32,877
| New | +$513K | 0.12% | 102 |
|